Author contributions
AT conducted the clinical trial, managed the participants, interpreted the data, and drafted and reviewed the manuscript. LO performed the anti-HIV activity experiments. NY performed the anti-HSV2 activity experiments. XF performed data analyses. PA and LB performed the pharmacokinetic analyses. HH analyzed the acceptability data. MC and OS supervised product development of the tablets. GD obtained funding, participated in product development and clinical study design. All authors contributed to the article and approved the submitted version.